NDAINTRAVENOUSSOLUTION
Approved
Oct 2025
Lifecycle
Launch
Competitive Pressure
0/100
Clinical Trials
2
Clinical Trials (2)
A Study to Determine the Dose Requirements of Rocuronium Bromide (Zemuron®) in Pediatric and Adolescent Subjects (21048)(COMPLETED)(P05797)
Started Oct 2004
149 enrolled
Anesthesia
Dose-Finding Trial With Sugammadex Administered at 3 and 15 Minutes After 1.0 and 1.2 mg/kg Rocuronium Bromide in Participants of ASA Class 1-3 (P05944; MK-8616-024)
Started Mar 2004
174 enrolled
Anesthesia, General
Loss of Exclusivity
LOE Date
Jul 22, 2039
162 months away
Patent Expiry
Jul 22, 2039
Patent Records (1)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 11998605 | Jul 22, 2039 | Product | — |
Company
B. Braun
Germany - Melsungen